DK1156830T3 - Anvendelse af en olie-i-vand emulsion til fremstilling af et lægemiddel - Google Patents

Anvendelse af en olie-i-vand emulsion til fremstilling af et lægemiddel

Info

Publication number
DK1156830T3
DK1156830T3 DK00914043T DK00914043T DK1156830T3 DK 1156830 T3 DK1156830 T3 DK 1156830T3 DK 00914043 T DK00914043 T DK 00914043T DK 00914043 T DK00914043 T DK 00914043T DK 1156830 T3 DK1156830 T3 DK 1156830T3
Authority
DK
Denmark
Prior art keywords
disease
chronic
acute
water emulsion
oil
Prior art date
Application number
DK00914043T
Other languages
Danish (da)
English (en)
Inventor
Heinrich Exner
Peter Klose
Original Assignee
Heinrich Exner
Peter Klose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Exner, Peter Klose filed Critical Heinrich Exner
Application granted granted Critical
Publication of DK1156830T3 publication Critical patent/DK1156830T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
DK00914043T 1999-02-24 2000-02-23 Anvendelse af en olie-i-vand emulsion til fremstilling af et lægemiddel DK1156830T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19910161 1999-02-24

Publications (1)

Publication Number Publication Date
DK1156830T3 true DK1156830T3 (da) 2006-05-29

Family

ID=7900130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00914043T DK1156830T3 (da) 1999-02-24 2000-02-23 Anvendelse af en olie-i-vand emulsion til fremstilling af et lægemiddel

Country Status (10)

Country Link
EP (1) EP1156830B1 (fr)
JP (1) JP4383678B2 (fr)
AT (1) ATE315408T1 (fr)
AU (1) AU3550400A (fr)
CA (1) CA2364606C (fr)
DE (2) DE10080402D2 (fr)
DK (1) DK1156830T3 (fr)
ES (1) ES2255988T3 (fr)
PT (1) PT1156830E (fr)
WO (1) WO2000050085A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10113284A1 (de) * 2001-03-16 2002-10-02 Heinrich Exner Adjuvans-Emulsion und Verfahren zu deren Verwendung
DE10313196A1 (de) * 2003-03-19 2004-10-07 Exner, Heinrich, Dr.med.vet. Verwendung einer Emulsion zur Prophylaxe und Therapie von Erkrankungen bei Tieren und Menschen
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
DE10353792A1 (de) * 2003-11-13 2005-06-23 Exner, Heinrich, Dr.med.vet. Heil- und Wundsalbe auf der Basis einer wässrigen Emulsion
DE102005009515A1 (de) 2005-02-25 2006-09-07 Exner, Heinrich, Dr. Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren
DE102007007698A1 (de) * 2007-02-09 2008-08-21 Exner, Heinrich, Dr. Verwendung einer hochemulgierten Silikonöl-Emulsion (HSE)zur Herstellung eines Medikamentes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445074A1 (de) * 1993-12-09 1995-06-29 Exner Heinrich Dr Med Vet Adjuvans für Antigene, Verfahren zur Herstellung und Verwendung
EP0732936B1 (fr) * 1993-12-09 2000-03-29 Heinrich Exner Adjuvant pour antigenes, son procede de production et son utilisation

Also Published As

Publication number Publication date
EP1156830B1 (fr) 2006-01-11
DE10080402D2 (de) 2002-05-08
AU3550400A (en) 2000-09-14
JP4383678B2 (ja) 2009-12-16
ES2255988T3 (es) 2006-07-16
CA2364606C (fr) 2012-02-14
PT1156830E (pt) 2006-05-31
EP1156830A2 (fr) 2001-11-28
WO2000050085A3 (fr) 2000-12-28
WO2000050085A2 (fr) 2000-08-31
DE50012052D1 (de) 2006-04-06
JP2002537359A (ja) 2002-11-05
CA2364606A1 (fr) 2000-08-31
ATE315408T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
GEP20053595B (en) Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
DK1819227T3 (da) Farmaceutisk formulering af decitabin
JP2009280627A5 (fr)
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
HUP0302334A2 (hu) Vírusellenes hatású nukleozid-vegyületek prekurzorjai, valamint e vegyületek alkalmazása gyógyászati készítmények előállítására
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
RU2003119460A (ru) Применение пэг-интерферона-а(пэг-inf-а) и рибавирина для лечения хронического гепатита с
NZ239558A (en) Pharmaceutical compositions containing perfluorinated hydrocarbons and silicones as liquid carriers
EE200300476A (et) 4-tsüanotrifluoro-3-(4-fluorofenüülsulfonüül)-2-hüdroksü-2-metüülpropiono-m-toluidii di ja PVP-d sisaldav tahke farmatseutiline kompositsioon
WO2002028372A3 (fr) Delivrance systemique de composes par administration non-invasive par la vessie
DK1156830T3 (da) Anvendelse af en olie-i-vand emulsion til fremstilling af et lægemiddel
WO2002102743A3 (fr) Aminoalkylesters d'acide diphenylalcoxy-acetique n et alpha-substitues deuterises et medicaments contenant lesdits composes
MA27474A1 (fr) Vaccin
JP2007518732A5 (fr)
WO2003007876A3 (fr) Conjugues acide amine-acide gras normal et utilisations therapeutiques
HUP0303379A2 (hu) Savérzékeny vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
CO5170447A1 (es) Derivado de benzamida y medicamento que lo contiene
SE0102887D0 (sv) New formulation
HUP0500642A2 (hu) Csökkentett toxicitású ciszplatin készítmények és eljárás alkalmazásukra
GEP20043301B (en) Heterocyclic Amide Derivatives, Pharmaceutical Compositions Containing the Same and Use Thereof for Treatment of Inflammation and Other Immune Disorders
CA2452920A1 (fr) Derives de benzo [g] quinoline destines au traitement du glaucome et de la myopie
NO20034453D0 (no) Anvendelse av CD25-bindende molekyler i steroid-resistente pasienter
JP2021506905A (ja) 血液中のＣａｎｄｉｄａ ａｕｒｉｓを処置するための方法および医薬組成物
EA200801973A1 (ru) Перфторуглеродная газопереносящая эмульсия для медико-биологических целей, способ ее получения и средство для лечения (варианты)